Argentina Medicinal Products Export Market -- HS Code 3004 Trade Data & Price Trend (Q3 2025)

Argentina Medicinal Products Export (HS 3004) Key Takeaways

Argentina's Medicinal Products Export under HS Code 3004 in Q3 2025 rebounded sharply, with values surging to $75.88 million in September after a mid-year slump, driven by a 0% export duty rate. The trade is dominated by high-value specialized medicaments, like hormone or antibiotic-based products, commanding premium prices up to $10.09 per unit. Uruguay leads by volume (34.77% share), while Brazil drives value (11.68%), reflecting demand for premium finished pharmaceuticals. This analysis, covering Q3 2025, is based on cleanly processed Customs data from the yTrade database.

Argentina Medicinal Products Export (HS 3004) Background

What is HS Code 3004?

HS Code 3004 covers medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, packaged in measured doses or retail-ready forms. These products are critical to global healthcare systems, driven by stable demand from pharmaceuticals, hospitals, and retail pharmacies. Their standardized packaging and dosage make them a key segment in international trade.

Current Context and Strategic Position

Argentina recently set a 0% export duty rate for certain goods, including medicinal products, until October 31, 2025, or until export sales reach US$7 billion [VAT Update]. This policy aims to boost Argentina's Medicinal Products Export competitiveness, particularly for HS Code 3004 trade data. Argentina's strategic position as a regional producer of pharmaceuticals underscores the importance of monitoring these policy shifts. With global demand for healthcare products remaining resilient, exporters must stay vigilant to capitalize on this temporary advantage.

Argentina Medicinal Products Export (HS 3004) Price Trend

Key Observations

In Q3 2025, Argentina's medicinal products exports under HS code 3004 demonstrated a sharp recovery, with values climbing from $0 in July to $75.88 million in September, following a period of volatility earlier in the year.

Price and Volume Dynamics

The Argentina Medicinal Products Export trend under HS code 3004 value trend peaked at $467.51 million in March before declining through April and May, then spiking to $170.28 million in June. The subsequent drop to zero in July was likely due to temporary disruptions, but the sequential growth in August and September aligns with Argentina's implementation of a 0% export duty rate for certain goods until October 2025, as reported by [KPMG], which provided incentives for exporters to resume shipments and capitalize on global demand cycles for pharmaceuticals.

Argentina Medicinal Products Export (HS 3004) HS Code Breakdown

Product Specialization and Concentration

Argentina's export of medicinal products under HS Code 3004 in Q3 2025 is heavily concentrated. According to yTrade data, one product dominates: "Medicaments; consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale" (HS 30049069990). It holds a 20% value share despite a 16% quantity share, with a unit price of $2.86 per unit, showing it drives premium value.

Value-Chain Structure and Grade Analysis

The remaining products fall into two clear groups. First, higher-value specialized medicaments, like those containing hormones or antibiotics, command prices from $5.56 to $10.09 per unit. Second, general medicaments and vitamin-based products trade at lower prices, from $1.38 to $3.02 per unit. This structure confirms trade in differentiated, finished goods, not bulk commodities, with pricing tied to therapeutic specificity and brand differentiation.

Strategic Implication and Pricing Power

For players in Argentina's HS Code 3004 export market, pricing power lies in high-specialization products. Suppliers should focus on developing and marketing advanced formulations, like antibiotic or hormone-based medicaments, which show stronger margins. Buyers seeking these goods must recognize that quality and therapeutic grade dictate cost, making supplier relationships and product certification key to securing reliable, high-value shipments.

Table: Argentina HS Code 3004) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3004 Breakdown

Argentina Medicinal Products Export (HS 3004) Destination Countries

Geographic Concentration and Dominant Role

In Q3 2025, Uruguay is the dominant destination for Argentina's Medicinal Products exports by volume, with a 34.77% quantity share, while Brazil leads in value share at 11.68%. The disparity between value and quantity shares reveals key patterns: Brazil's higher value share compared to quantity (11.68% vs. 9.22%) indicates demand for premium or finished pharmaceuticals. Uruguay's much higher quantity share than value (34.77% vs. 11.56%) suggests bulk shipments of lower-end or generic Medicinal Products. Paraguay shows a high frequency share of 13.09%, pointing to frequent, small-ticket trade, likely for retail or regular supply chain replenishment.

Destination Countries Clusters and Underlying Causes

The top destinations cluster into three groups based on trade profiles. The High-Yield Cluster includes Brazil and Turkey, where value shares exceed quantity shares, indicating premium pricing for specialized Medicinal Products, possibly due to higher regulatory standards or brand demand. The Volume Cluster is centered on Uruguay, with its dominant quantity share, acting as a hub for bulk purchases or regional distribution. The Transactional Cluster features Paraguay and Ecuador, characterized by high frequency shares, which may stem from cross-border retail networks or just-in-time delivery systems for pharmaceuticals, ensuring steady supply.

Forward Strategy and Supply Chain Implications

To enhance Argentina Medicinal Products export performance, focus on high-margin markets like Brazil and Turkey by promoting premium product lines. For volume-driven partners like Uruguay, optimize logistics and cost efficiency for bulk shipments. The recent 0% export duty rate implemented in Argentina [VAT Update] in September 2025 could support export growth for included goods, potentially benefiting HS Code 3004 trade by reducing costs and increasing competitiveness in key markets.

Table: Argentina Medicinal Products (HS 3004) Top Destination Countries (Source: yTrade)

Get Complete Destination Countries Profile

Action Plan for Medicinal Products Market Operation and Expansion

• Target Brazil and Turkey with high-specification antibiotic or hormone-based medicaments, as the hs code 3004 trade data shows these markets pay premium prices for specialized products, directly boosting margins for the Argentina Medicinal Products Export.
• Streamline bulk shipment logistics for high-volume, lower-margin trade with Uruguay to cut costs and protect profitability, a key step in optimizing the entire Medicinal Products supply chain.
• Use the recent 0% export duty to competitively price premium products in all markets, making the Argentina Medicinal Products Export more attractive and increasing overall trade volume.
• Build direct relationships with frequent, smaller buyers in Paraguay to secure stable order flow and reduce supply chain vulnerability, ensuring consistent revenue for your hs code 3004 trade data strategy.

Take Action Now —— Explore Argentina Medicinal Products Export Data

Frequently Asked Questions

Q1. What is driving the recent changes in Argentina Medicinal Products Export 2025 Q3?

Argentina's medicinal exports rebounded sharply in Q3 2025, reaching $75.88 million in September after a July slump, likely due to the 0% export duty rate implemented in September, which incentivized shipments.

Q2. Who are the main destination countries of Argentina Medicinal Products (HS Code 3004) 2025 Q3?

Uruguay dominates by volume (34.77%), while Brazil leads in value (11.68%). Paraguay also shows high frequency (13.09%), indicating frequent small shipments.

Q3. Why does the unit price differ across destination countries of Argentina Medicinal Products Export?

Price differences stem from product specialization—Brazil and Turkey demand premium formulations (e.g., hormone/antibiotic-based medicaments at $5.56–$10.09/unit), while Uruguay imports lower-cost generics ($1.38–$3.02/unit).

Q4. What should exporters in Argentina focus on in the current Medicinal Products export market?

Exporters should prioritize high-margin markets like Brazil and Turkey by promoting specialized medicaments, while optimizing bulk logistics for volume-driven partners like Uruguay.

Q5. What does this Argentina Medicinal Products export pattern mean for buyers in partner countries?

Buyers in Brazil and Turkey must prioritize supplier relationships for premium products, while those in Uruguay and Paraguay benefit from cost-efficient bulk or frequent small shipments.

Q6. How is Medicinal Products typically used in this trade flow?

Argentina’s HS Code 3004 exports consist mainly of finished retail pharmaceuticals, including specialized (e.g., antibiotic-based) and generic medicaments, not bulk commodities.

Detailed Monthly Report

Argentina HS3004 Export Snapshot 2025 JUL

Argentina HS3004 Export Snapshot 2025 SEP